Obesity & CVS Issues
Obesity affects the cardiovascular system in multiple ways. Obese individuals have an increased total blood volume to meet the perfusion needs of the increased adipose tissue. Cardiac and stroke work indices remain normal in normotensive obese individuals. The increase in cardiac output is also accompanied by a decrease in systemic vascular resistance in normotensive obese individuals. Because of increased LV workload, oxygen consumption is also increased; the oxygen consumption increases linearly with the increase in body weight. On the whole, overweight and obesity predispose to or are associated with numerous cardiac complications such as coronary heart disease, heart failure.
- Obesity and Coronary Heart Disease
- Cardiovascular Impact Adipose Tissue
- Congestive Heart Failure
- Treatment of Obesity and Heart Disease
- Weight Control Reduce heart disease
- Case study of diabetic patients undergoing cardiac surgery
- Heart Disease
- Obesity, Asthma & Allergies: the Inflammatory Connection
- Overweight and Risk of Seasonal Asthma
- Asthma & Other Respiratory Problems Linked to Obesity
- Artheroscelorosis
Related Conference of Obesity & CVS Issues
Obesity & CVS Issues Conference Speakers
Recommended Sessions
- Anti-Obesity Drugs
- Bariatric therapy
- Childhood Obesity
- Clinical Research and Interventions
- Complications in Obesity
- Consequences of Obesity and Cancer
- Current research on Obesity
- Epidemiology of Obesity
- Genetic links of Obesity
- Health, Behaviour and Environment
- Insights on Nutritional Findings and Eating Disorders
- Metabolic syndromes & Anorexia
- New Directions in Obesity Treatment
- Obesity & CVS Issues
- Obesity & Endocrinology
- Obesity and its Causes
- Obesity in women
- Prevention of obesity
- Ties Between Obesity and Diabetes
- Weight Management
- Yoga and Naturopathy
Related Journals
Are you interested in
- Advanced Treatment in Obesity - WORLD OBESITY-2024 (Spain)
- Anti-Obesity Drugs - Euro Obesity 2024 (UK)
- Anti-obesity drugs - WORLD OBESITY-2024 (Spain)
- Anti-Obesity Drugs and Weight-Loss Supplements - CHRONIC OBESITY 2024 (Indonesia)
- Ayurveda and Naturopathic Medicine - CHRONIC OBESITY 2024 (Indonesia)
- Bariatric Surgery - WORLD OBESITY-2024 (Spain)
- Behavioral Therapy - Euro Obesity 2024 (UK)
- Challenges and Prevention of Chronic Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Childhood Obesity - WORLD OBESITY-2024 (Spain)
- Childhood Obesity and Effects - Euro Obesity 2024 (UK)
- Chronic Respiratory Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Current Research on Obesity - CHRONIC OBESITY 2024 (Indonesia)
- Current research on obesity and diet - WORLD OBESITY-2024 (Spain)
- Diabesity: A Dual Challenge - WORLD OBESITY-2024 (Spain)
- Diabetes and Metabolic Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Diet & Nutrition - Euro Obesity 2024 (UK)
- Diet and nutrition - WORLD OBESITY-2024 (Spain)
- Dietary and Lifestyle changes - Euro Obesity 2024 (UK)
- Digital Therapeutics of Chronic Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Genetic Obesity - CHRONIC OBESITY 2024 (Indonesia)
- Genetics and Epigenetics of Obesity - WORLD OBESITY-2024 (Spain)
- Genetics of obesity - Euro Obesity 2024 (UK)
- Gynaecology & Obstetrics - Euro Obesity 2024 (UK)
- Gynecology and Obstetrics - WORLD OBESITY-2024 (Spain)
- HIV/ AIDS - CHRONIC OBESITY 2024 (Indonesia)
- Liposuction - Euro Obesity 2024 (UK)
- Liposuction and Advanced Weight Loss Treatments - CHRONIC OBESITY 2024 (Indonesia)
- Metabolic health - WORLD OBESITY-2024 (Spain)
- Morbid Obesity and Chronic Obstructive Pulmonary Disease (COPD) - CHRONIC OBESITY 2024 (Indonesia)
- Non-Surgical Treatment for Obesity - Euro Obesity 2024 (UK)
- Nutrition and Dietary Interventions - WORLD OBESITY-2024 (Spain)
- Nutritional counselling - WORLD OBESITY-2024 (Spain)
- Obesity - Euro Obesity 2024 (UK)
- Obesity - WORLD OBESITY-2024 (Spain)
- Obesity & Associated Health Disorders - Euro Obesity 2024 (UK)
- Obesity & Metabolic Disorders - Euro Obesity 2024 (UK)
- Obesity and Cancer - CHRONIC OBESITY 2024 (Indonesia)
- Obesity and Cardiovascular Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Obesity and Diabetes - Euro Obesity 2024 (UK)
- Obesity and Diet - CHRONIC OBESITY 2024 (Indonesia)
- Obesity and Endocrinology - Euro Obesity 2024 (UK)
- Obesity and Metabolic Diseases - WORLD OBESITY-2024 (Spain)
- Obesity and Pregnancy: Risk Factors - CHRONIC OBESITY 2024 (Indonesia)
- Obesity Causes - Euro Obesity 2024 (UK)
- Obesity Epidemiology - WORLD OBESITY-2024 (Spain)
- Obesity in Real Life - Euro Obesity 2024 (UK)
- Obesity in Teens and Adolescents - Euro Obesity 2024 (UK)
- Obesity in Teens and Adolescents - WORLD OBESITY-2024 (Spain)
- Obesity: Child, Teens, Adolescence - CHRONIC OBESITY 2024 (Indonesia)
- Obesity: Current research - Euro Obesity 2024 (UK)
- ozone therapy for obesity and chronic diseases - CHRONIC OBESITY 2024 (Indonesia)
- Paediatric Obesity - CHRONIC OBESITY 2024 (Indonesia)
- Physical activity, Exercise and Kinesiology - WORLD OBESITY-2024 (Spain)
- Prevention: Obesity - Euro Obesity 2024 (UK)
- Risk Factors Associated with Obesity - CHRONIC OBESITY 2024 (Indonesia)
- Roles of Steroids and Hormones in Obesity - WORLD OBESITY-2024 (Spain)
- Thyroid and Auto Immune Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Weight Management - WORLD OBESITY-2024 (Spain)
- Yoga, Counselling and Physical Therapy - CHRONIC OBESITY 2024 (Indonesia)